Oruka Therapeutics (ORKA) Misses Q4 EPS by 45c

Oruka Therapeutics (NASDAQ: ORKA) reported Q4 EPS of ($0.45). Revenue for the quarter came in at $0.

For earnings history and earnings-related data on Oruka Therapeutics (ORKA) click here.

You May Also Be Interested In

• US Eyes 7.5% China Overcapacity Tariffs Before Xi-Trump Talks - Bloomberg
• Strategy (MSTR) call put ratio 2.1 calls to 1 put with a focus on August 28 weekly calls as share price up 5.1%
• XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook